Tue, August 31, 2021
Mon, August 30, 2021
Fri, August 27, 2021

Raghuram Selvaraju Maintained (AXSM) at Strong Buy with Decreased Target to $180 on, Aug 30th, 2021

Raghuram Selvaraju of HC Wainwright & Co., Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Decreased Target from $225 to $180 on, Aug 30th, 2021.

Raghuram has made no other calls on AXSM in the last 4 months.



There are 5 other peers that have a rating on AXSM. Out of the 5 peers that are also analyzing AXSM, 1 agrees with Raghuram's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $34 on, Tuesday, August 10th, 2021


These are the ratings of the 4 analyists that currently disagree with Raghuram


  • Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $160 on, Tuesday, August 10th, 2021
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $75 on, Tuesday, August 10th, 2021
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Decreased Target to $55 on, Tuesday, August 10th, 2021
  • Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $112 on, Thursday, June 10th, 2021